Director / Senior Director
cAMPfield Therapeutics
Director / Senior Director
cAMPfield Therapeutics
Develops oral PDE4 inhibitors for IBD
Director / Senior Director - Clinical Operations
Location: Hybrid – Boston, MA
Employment Type: Full‑time
Reports to: SVP, Clinical Development Operations
About the Role
The Director / Senior Director, Clinical Operations is accountable for end‑to‑end operational leadership of a global Phase II clinical study, ensuring delivery on time, within budget, and with high quality. This role is ideal for a seasoned clinical operations leader who thrives in fast‑paced biotech environments, excels at strategic decision‑making, and can translate program goals into operational reality. The Director / Senior Director, Clinical Operations will partner closely with Clinical Development, Medical Affairs, Regulatory, Biometrics, Safety, and external CROs/vendors to ensure seamless execution across regions.
Key Responsibilities
Study Strategy & Planning
Study Execution & Oversight
Vendor & Site Management
Data, Quality & Compliance
Cross‑Functional Leadership
Budget & Resource Management
Qualifications
Develops oral PDE4 inhibitors for IBD
cAMPfield Therapeutics develops oral small-molecule therapies for inflammatory and immunological diseases. Its lead program, prifemilast, is an oral PDE4 inhibitor being developed for inflammatory bowel disease (IBD), including ulcerative colitis. The drug’s mechanism targets PDE4 to reduce inflammation, and prifemilast has shown efficacy in Phase 2 studies for ulcerative colitis. The company focuses on in-licensing assets with potential to transform patient care and aims to establish prifemilast as a preferred IBD treatment with a favorable safety profile. Global rights to prifemilast (also known as HPP737) were acquired from vTv Therapeutics and Newsoara Biopharma. cAMPfield recently launched with a $180 million Series A led by top-tier investors, signaling growth plans and potential partnerships. The company’s goal is to bring a best-in-class oral PDE4 inhibitor to patients and pursue collaborations that advance its clinical programs.
Explore more opportunities at cAMPfield Therapeutics